Kouli A, Torsney KM, Kuan WL (2018) Parkinsons disease: etiology, neuropathology, and pathogenesis
In public comments, Kaiser leaders spoke of the acquisition as an opportunity for Risant to improve the health of millions of people by increasing access to value-based care and coverage, and raising the bar for value-based approaches that prioritize patient quality outcomes. Many of the experts I spoke with understand Kaisers value intent
Multiple factors are supporting this leadership, including a high prevalence of obesity, advanced healthcare infrastructure, and strong pharmaceutical innovation ecosystems
These findings provide novel strategies for improving metabolic diseases through gut microbiota modulation
Schmidt CK, Khalid S, Loukas M, Tubbs RS